E ISSN: 2583-049X
logo

International Journal of Advanced Multidisciplinary Research and Studies

Volume 6, Issue 4, 2026

Identification, Monitoring, and Management of Chronic Kidney Disease at University Hospital Kerry: Findings from a Multidisciplinary Clinical Audit



Author(s): Dr. Khalid Ghalib, Dr. Mazin Mohamed, Mouraa O'connor, Dr. Yousif R Makki, Jose Rani Yeruva, Nada Hassan Ahmed Abdelrahman, Aditi Gupta, Sobia Jamil, Ola Abuzied, Kevin Hii, Lena Hamza, Alweena Batool, Musa Kaleem Ullah, Khalid Elgalal, Zeeshan Alam, Ambreen Naz, Audrey Wiredu Appiah, Dr. Ahmed Elnour, Mohammed Siraj, Essam Arabi

Abstract:

Background: Chronic kidney disease (CKD) affects a substantial proportion of adults and is associated with cardiovascular risk, progression to kidney failure, and medication-related harm [1-4]. Structured identification, staging, and guideline-directed management are central to improving outcomes.

Aim: To assess local compliance with evidence-based standards for the identification, monitoring, and management of patients with CKD at University Hospital Kerry (UHK), and to identify targets for quality improvement.

Methods: A retrospective multidisciplinary clinical audit of 38 patient records was undertaken against eight locally agreed standards derived from national and international CKD guidance [1, 2]. Data on CKD staging, albuminuria assessment, blood pressure monitoring and control, renoprotective prescribing, medication review, renal function monitoring, and nephrology referral were collected and compared against target thresholds.

Results: The cohort was predominantly female (68.4%, 26/38) with an age range of approximately 53–92 years. Only two of eight standards were met: blood pressure monitoring (100%, 38/38) and renal function monitoring (100%, 38/38). CKD stage was documented in 34.2% (13/38) of patients against a 95% standard; urine albumin-to-creatinine ratio (ACR) was recorded in 28.9% (11/38) against a 90% standard, with no patient having a documented albuminuria category. Medication review performance was mixed: nephrotoxic medicines were reviewed in 86.8% (33/38) of patients, whereas regular/ongoing medicines were reviewed in only 31.6% (12/38), against a 90% standard for each. Nephrology referral was completed in 62.9% (17/27) of patients meeting referral criteria, against a 100% standard.

Conclusion: Routine monitoring activities were well embedded, but structured CKD staging, albuminuria assessment, renoprotective prescribing, and nephrology referral fell substantially short of target standards. A standardised CKD documentation and alert tool, together with staff education, is proposed, with re-audit planned at 6 months.


Keywords: Chronic Kidney Disease, Clinical Audit, Medication Review, Renoprotective Therapy, Nephrology Referral, Quality Improvement

Pages: 1162-1167

Download Full Article: Click Here